GlassScriptPhysician profile
Jency M Elakkatt
NPI 1730378647
$3,317.05
in general payments reported to CMS, 2019-2025
17 companies · $554 in 2025
The $554 reported for 2025 was more than what 80% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19.69 · 2020: $15.72 · 2021: $274 · 2022: $1,774 · 2023: $216 · 2024: $463 · 2025: $554.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,134 · Entertainment: $99.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,133.93 |
| Entertainment | $99.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,215.79 | 2022-2025 | Eysuvis, Tryptyr |
| Bausch & Lomb Americas INC. | $552.03 | 2022-2025 | Xiidra, Miebo, Envista Mx60 Iol |
| Eyevance Pharmaceuticals LLC | $277.69 | 2021-2022 | |
| Oyster Point Pharma, INC. | $262.59 | 2022-2025 | Tyrvaya, Ryzumvi, Ryzumvi |
| Harrow Eye, LLC | $253.73 | 2025 | Vevye |
| Coopervision INC. | $136.96 | 2023-2024 | Misight Contact Lens, Onefit Contact Lens |
| Sight Sciences, INC. | $121.96 | 2021-2022 | |
| Optos, INC. | $99.59 | 2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Johnson & Johnson Vision Care, INC. | $90.49 | 2024 | |
| Tarsus Pharmaceuticals, INC. | $71.04 | 2024-2025 | Xdemvy |
| Amgen INC. | $64.93 | 2025 | Tepezza |
| Rxsight INC | $46.26 | 2021-2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Injector Cartridge |
| Ivantis, INC | $35.91 | 2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $35.41 | 2019-2020 | |
| Mallinckrodt Hospital Products INC. | $24.69 | 2025 | Acthar |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Thea Pharma INC. | $14.83 | 2025 | Iyuzeh |
| Tearlab Corp | $13.15 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jency Elakkatt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.